What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?
Specialized “premium” therapy sales in growth markets is a strategic focus in the industry, and patient services offerings play an increasing role in achieving this goal. The development of patient programs in developing countries requires calibration to nuances of the local context, particularly for out-of-pocket markets.
What is the best approach for defining patient services strategy for premium treatments in emerging, out-of-pocket markets?
This white paper has been written by our consultants Kevin Maples and Francesca Schneller
Share
See also

News
The Observia crew wishes you a Happy Holiday Season!

Success Stories
Building a scalable ePRO platform

Scientific communications
Usage of the SPUR™ Adherence Profiling Tool in depression and anxiety: Initial Findings
Need more information?
A burning question, a specific request, a great project to share with us? Get in touch, our teams are here to help!
